In order to find the clinic correlation of cyclin D1 and reveal the mechanism of the genome-wide cyclin D1 binding sites and the changes of downstream genes in cancer, we firstly analyzed the correlation between cyclin D1 expression and prognosis in the tissue microarray (TMA) cohort. This evidence concerns the gene CCND1 and cancer.